Owlstone raises £22m for Breath Biopsy diagnostic tests
A Cambridge MedTech behind a ‘Breath Biopsy’ platform which aims to diagnose disease has raised £22m in Series E funding. … Continue reading Owlstone raises £22m for Breath Biopsy diagnostic tests
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
